Delivery Order SPE2DB20D2001-SPE2DB25FPNCV
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a medication, with a firm fixed price of $1,848.78 and a completion date of May 15, 2025. The contract is not set aside and was awarded on May 14, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of RIFAMPIN 300 MG CAPSULE 60S. The contract has a ceiling value of $1,024.77 and is a firm fixed-price, non-set-aside award with a period of performance through July 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product. It is a firm fixed-price contract with a ceiling value of $1,221.96 and an ultimate completion date of July 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a medication, with a firm fixed price ceiling value of $3,863.07. The period of performance extends through June 17, 2025. This award is not associated with a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RIFAMPIN 300 MG CAPSULE UD 100S. The contract has a firm fixed price, a ceiling value of $11,383.20, and an ultimate completion date of June 24, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,187.50 firm-fixed-price contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a medication. The order has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. The company also holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RIFAMPIN 300MG CAP 60S. The contract has a ceiling value of $7,350.32 and is a firm fixed-price delivery order, with an ultimate completion date of August 1, 2025. The contract is not set-aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, one of the largest pharmaceutical distributors in the United States. The contract is for the delivery of Rifampin 300 mg capsules, a critical antibiotic medication, with a ceiling value of $2,148.60 and a completion date of September 25, 2024. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,160,692 units of Rifampin 300 mg capsules. The contract has a ceiling value of $5,109.58 and a period of performance through May 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RIFAMPIN 300 MG CAPSULE 60S. The contract has a ceiling value of $37,446.85 and a period of performance through February 11, 2025. This is not a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNCVDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product, with a ceiling value of $5,991.41 and a completion date of July 14, 2025. The contract is a firm-fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 7/11/25 |